1,2-diheptanoyl-sn-glycero-3-phosphocholine , >99% , 39036-04-9

CAS NO.：39036-04-9

Empirical Formula: C22H44NO8P

Molecular Weight: 481.57

MDL number: MFCD00063532

PRODUCT Properties

• storage temp.: −20°C
• solubility: DMF: > 20 mg/ml; DMSO: > 7 mg/ml; Ethanol: > 30 mg/ml; PBS (pH 7.2): > 250 μg/ml
• form: solution
• InChI: 1S/C22H44NO8P/c1-6-8-10-12-14-21(24)28-18-20(31-22(25)15-13-11-9-7-2)19-30-32(26,27)29-17-16-23(3,4)5/h20H,6-19H2,1-5H3/t20-/m1/s1
• InChIKey: RBFSPQDASPEAID-HXUWFJFHSA-N
• SMILES: [P](=O)([O-])(OC[C@H](OC(=O)CCCCCC)COC(=O)CCCCCC)OCC[N+](C)(C)C

Description and Uses

L-α-Diheptanoyllecithin is used in novel therapies for treating and preventing chronic rhinosinusitis by disrupting preformed bacterial biofilm using antibiotics in combination with phospholipids.

Safety

• Symbol(GHS): GHS06,GHS08
• Signal word: Danger
• Hazard statements: H302-H315-H319-H331-H336-H351-H361d-H372-H412
• Precautionary statements: P201-P273-P301+P312+P330-P302+P352-P304+P340+P311-P308+P313
• target organs: Central nervous system, Liver,Kidney
• Hazard Codes: Xn
• Risk Statements: 22-38-40-48/20-48/22-48/20/22-67-36/38-20-63
• Safety Statements: 2-36/37-26
• RIDADR: UN 1888 6.1/PG 3
• WGK Germany: 3
• Hazard Classifications: Acute Tox. 3 Inhalation; Acute Tox. 4 Oral; Aquatic Chronic 3; Carc. 2; Eye Irrit. 2; Repr. 2; Skin Irrit. 2; STOT RE 1; STOT SE 3